A recent study on T cell gene therapy trials shows that while secondary malignancies occur in a small percentage of patients, ...

Patna: Health minister, Mangal Pandey, informed the legislative council on Tuesday that HIV cases have shown a declining trend in the past three years.

To determine the titre of MLV and HIV vector stocks, we used serial dilution of concentrated virus to infect 5×10 5 HeLa cells in a 6-well plate in the presence of polybrene (8 μgsol;ml).

One avenue for new vaccine development is mucosal vaccines. In theory, dosing the vaccine directly into the respiratory tract ...

ICMR-NIV director discusses India's expanding VRDL network, vaccine manufacturing, viral disease surveillance, and One Health ...

The news is concerning in both the short term and the long term. Supply of life-saving medical products could be delayed by ...

Manipal Institute of Virology (MIV) celebrated its Annual Day and Alumni Meet 2025 at Dr TMA Pai Auditorium, MAHE, Manipal, ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

HIV infections (human immunodeficiency virus infections) include the spectrum of infections caused by the virus HIV that range from asymptomatic seropositivity to acquired immunodeficiency ...

An annual injection designed to guard against Human Immunodeficiency Virus (HIV) has completed an important early safety trial, researchers report in The Lancet medical journal. Lenacapavir stops ...